Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv crawled time : 07:00 save search
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union
Published: 2024-01-09 (Crawled : 07:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.56%
H: 1.26%
C: 0.55%
produodopa disease abbvie parkinson's advanced living
Industrial Automation Market outlooks 2027|Market size of the historic period(2017 to 2021), Market size of the forecast period (2023-2027), Growth rate | Technavio
Published: 2023-07-27 (Crawled : 07:00) - prnewswire.com
ABBNY | News | $48.37 4.05% 180K
|
n/a
|
| O: 2.13%
H: 0.04%
C: -1.67%
ABLZF | News | $48.065 -32.74% 4.7K
|
Producer Manufacturing
|
| O: 0.58%
H: 0.0%
C: -0.46%
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: -2.18%
H: 0.2%
C: -3.58%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 2.13%
H: 4.77%
C: 3.02%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.31%
H: 1.71%
C: 0.67%
growth market
Oil Refining Market all set to rise at growth rate of 1.42% CAGR | Valuation at $121.92 billion between 2022-2027
Published: 2023-07-27 (Crawled : 07:00) - prnewswire.com
BPAQF | $6.45 7.53% 5.1K
|
Energy Minerals
|
| O: 6.73%
H: 0.95%
C: -5.36%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 2.13%
H: 4.77%
C: 3.02%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.31%
H: 1.71%
C: 0.67%
set growth market
AbbVie's VENCLYXTO®/VENCLEXTA® (venetoclax) Continues to Show Sustained Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) Patients
Published: 2023-06-09 (Crawled : 07:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.06%
H: 1.18%
C: 0.45%
venclyxto leukemia show
Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023
Published: 2023-06-09 (Crawled : 07:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.3%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.06%
H: 1.18%
C: 0.45%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.44%
H: 0.18%
C: -0.44%
association lymphomas meeting program
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease
Published: 2023-04-17 (Crawled : 07:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.2%
H: 0.17%
C: -0.46%
rinvoq disease abbvie active approval treatment
Optic Nerve Disorder Treatment Market to Reach USD 5.3 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published: 2023-02-27 (Crawled : 07:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.74%
H: 0.7%
C: -1.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.64%
H: 0.01%
C: -0.72%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.36%
H: 0.97%
C: 0.67%
treatment research market
Breast Cancer Therapeutics Market Size to Grow by USD 13.85 Bn, Targeted Therapy to be Largest Revenue-generating Product Segment - Technavio
Published: 2022-10-27 (Crawled : 07:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.47%
H: 0.21%
C: -0.7%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.1%
H: 0.85%
C: -1.1%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.06%
H: 0.44%
C: -0.15%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.12%
H: 0.47%
C: 0.21%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.82%
H: 0.15%
C: -0.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K
|
Health Technology
|
| O: 1.32%
H: 0.43%
C: -3.46%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.48%
H: 0.56%
C: -0.12%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.5%
H: 0.49%
C: -0.29%
breast therapeutics therapy cancer market
Beta-Lactam And Beta-Lactamase Inhibitors Market to grow by USD 9.04 Bn, Pharmaceutical Market to be Parent Market - Technavio
Published: 2022-10-17 (Crawled : 07:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.61%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 1.05%
H: 0.62%
C: -0.41%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.36%
H: 0.23%
C: -0.1%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.15%
H: 0.67%
C: -0.22%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.2%
H: 1.6%
C: 1.23%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.2%
H: 1.79%
C: 1.37%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.51%
H: 0.95%
C: 0.65%
market
Hyaluronic Acid Raw Material Market Size to Grow by USD 2.87 billion, Need For Safe and Stable Drugs that Require Minimal Monitoring to Boost Market Growth - Technavio
Published: 2022-09-26 (Crawled : 07:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 5.77%
H: 0.0%
C: -2.27%
ALC | $79.55 1.38% -0.25% 1.1M
|
Health Technology
|
| O: -4.07%
H: 2.4%
C: 1.72%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.69%
H: 0.51%
C: -0.61%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.29%
H: 0.35%
C: -0.67%
ANIK | $25.84 1.61% 1.59% 49K
|
Health Technology
|
| O: 0.0%
H: 1.28%
C: -0.85%
growth market
Obsessive-Compulsive Disorder Drugs Market, Rising Prevalence Of OCD to Boost Market Growth - Technavio Research Reports
Published: 2022-08-23 (Crawled : 07:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -1.35%
H: 1.18%
C: -0.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.91%
H: 0.1%
C: -0.17%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.88%
H: 0.3%
C: -0.06%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.49%
H: 0.86%
C: -0.45%
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -0.02%
H: 0.79%
C: -0.36%
research growth market
Hairy Cell Leukemia Therapeutics Market Size to Grow by USD 177.85 million, Majority of Growth to Originate from North America - Technavio
Published: 2022-08-22 (Crawled : 07:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.39%
H: 1.09%
C: 1.09%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.66%
H: 0.1%
C: -1.43%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.08%
H: 0.49%
C: -1.15%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.49%
H: 1.11%
C: -0.39%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.35%
H: 0.5%
C: -1.23%
america leukemia therapeutics growth market
Head And Neck Cancer Diagnostics Market Size to Grow by USD 4.22 billion, Increasing Incidences of Head and Neck Cancers to Drive Growth - Technavio
Published: 2022-08-22 (Crawled : 07:00) - prnewswire.com
RYLPF | News | $20.515 3.85% 7K
|
Health Technology
|
| O: -3.94%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.08%
H: 0.49%
C: -1.15%
diagnostics cancer growth market
RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis
Published: 2022-07-29 (Crawled : 07:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -4.04%
H: 0.0%
C: 0.0%
rinvoq treatment active approved
European Commission Approves RINVOQ® (upadacitinib) for the Treatment of Adults With Moderate to Severe Ulcerative Colitis
Published: 2022-07-26 (Crawled : 07:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
rinvoq treatment ulcerative colitis
AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine
Published: 2022-07-18 (Crawled : 07:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: 0.0%
treatment ema application migraine authorization
CHMP Recommends Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis
Published: 2022-06-27 (Crawled : 07:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.55%
H: 0.0%
C: 0.0%
rinvoq treatment active chmp approval
Breast Implant Market Forecast Report 2021: USD 437.17 Million Market Growth Opportunity by 2025| Technavio
Published: 2022-06-14 (Crawled : 07:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.04%
H: 0.87%
C: -1.31%
ESTA | $47.425 -9.79% -10.85% 430K
|
Health Technology
|
| O: -1.29%
H: 0.42%
C: -0.24%
report implant growth market
CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis
Published: 2022-05-23 (Crawled : 07:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
rinvoq treatment chmp approval ulcerative colitis
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.31%
H: 0.53%
C: -0.19%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.72%
H: 1.09%
C: -9.3%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.17%
H: 0.59%
C: -1.52%
ACAD | $16.82 -1.47% -1.49% 3.5M
|
Health Technology
|
| O: -3.61%
H: 1.39%
C: -3.14%
europe disease growth market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.